The abovementioned results indicate that ODZ10117 is a potential STAT3 inhibitor in glioblastoma and the effect is greater than that of the known STAT3 inhibitors such as S3I-201, STA-21, nifuroxazide, and AG-490. The gene discussed is STAT3; the disease is glioblastoma.